Edgewise Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
Edgewise Therapeutics, Inc. (EWTX) had Stock Issued During Period, Shares, New Issues of 9.94 million shares as of 2025-04-03, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-08-06
- 2025-04-03: Stock Issued During Period, Shares, New Issues 9.94M shares.
- 2024-01-23: Stock Issued During Period, Shares, New Issues 21.82M shares.
- 2022-09-16: Stock Issued During Period, Shares, New Issues 13.37M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2025-04-03 | 9.94M shares 10-Q · filed 2026-08-06 |
| 2024-01-23 | 21.82M shares 10-Q · filed 2025-11-06 |
| 2022-09-16 | 13.37M shares 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |